Nipro Corporation (TYO:8086)

Japan flag Japan · Delayed Price · Currency is JPY
1,536.00
+3.50 (0.23%)
Mar 10, 2026, 9:35 AM JST
15.92%
Market Cap 249.94B
Revenue (ttm) 652.61B
Net Income (ttm) 15.20B
Shares Out 163.10M
EPS (ttm) 82.58
PE Ratio 18.56
Forward PE 18.45
Dividend 28.00 (1.80%)
Ex-Dividend Date Mar 30, 2026
Volume 90,600
Average Volume 828,085
Open 1,558.50
Previous Close 1,532.50
Day's Range 1,532.00 - 1,560.00
52-Week Range 1,230.50 - 1,598.50
Beta -0.06
RSI 52.85
Earnings Date Feb 9, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’... [Read more]

Sector Healthcare
Founded 1947
Employees 39,168
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 8086
Full Company Profile

Financial Performance

In fiscal year 2025, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.

Financial Statements

News

There is no news available yet.